BIM:EPA
BioMerieux SA
€87.25
arrow_upward
+1.16%(+1.00) 1D
Oct 22, 12:30:16 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BIM...
Open
€86.45
High
€87.40
Low
€86.45
Mkt. cap
10.33B
Avg. vol.
165.10K
Volume
20.47K
P/E ratio
22.36
52-wk high
€116.10
52-wk low
€65.60
EPS
€3.90
Shares outstanding
118.36M
No. of employees
15K
Open
€86.45
High
€87.40
Low
€86.45
Mkt. cap
10.33B
Avg. vol.
165.10K
Volume
20.47K
P/E ratio
22.36
52-wk high
€116.10
52-wk low
€65.60
EPS
€3.90
Shares outstanding
118.36M
No. of employees
15K
News stories
From web sources and news partners
The Lufkin Daily News
·
29 minutes ago
Chemicals maker Dow beats third-quarter profit estimates
Traders Union
·
7 minutes ago
Nearly half of S&P 500 companies to announce earnings in one week, Lance Roberts notes
FXEmpire
·
25 minutes ago
S&P 500 and Nasdaq 100: Asia Selloff and Tesla Weakness Pressure Futures Despite Meta Beat
شبكة تواصل الإخبارية
·
2 hours ago
Equities: Tesla clouds the tech rally despite Meta beat – Deutsche Bank | FXStreet
Profile
bioMérieux SA is a French multinational biotechnology company founded and headquartered in Marcy-l'Étoile, France, close to Lyon. bioMérieux is present in 44 countries and serves more than 160 countries through a large network of distributors.
bioMérieux provides diagnostic solutions which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are used for diagnosing infectious diseases, cancer screening, and monitoring and cardiovascular emergencies. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products. bioMérieux is listed on the Euronext Paris stock exchange. Wikipedia
About BioMerieux SA
CEOPierre Boulud
Employees14.9K
Founded1963
HeadquartersMarcy-l'Étoile, Rhone-Alpes, France
SectorMedical device
Websitebiomerieux.com